References
- Amagai, M., V. Klaus-Kovtun, and J. R. Stanley. 1991. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 67: 869–877
- Hertl, M., and C. Veldman. 2001. Pemphigus – paradigm of autoantibody-mediated autoimmunity. Skin Pharmacol. Appl. Skin Physiol. 14: 408–418
- Robinson, N. D., T. Hashimoto, M. Amagai, and L. S. Chan. 1999. The new pemphigus variants. J. Am. Acad. Dermatol. 40: 649–671
- Hashimoto, T. 2003. Recent advances in the study of the pathophysiology of pemphigus. Arch. Dermatol. Res. 295: S2–S11
- Kumar, K. A. 2008. Incidence of pemphigus in Thrissur district, south India. Indian J. Dermatol. Venereol. Leprol. 74: 349–351
- Sinha, A. A. 2011. The genetics of pemphigus. Dermatol. Clin. 29: 381–391
- Bidwell, J., L. Keen, G. Gallagher, et al. 1999. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1: 3–19
- Hollegaard, M. V., and J. L. Bidwell. 2006. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 7: 269–276
- Narbutt, J., J. Lukamowicz, J. Bogaczewicz, et al. 2008. Serum concentration of interleukin-6 is increased both in active and remission stages of pemphigus vulgaris. Mediat. Inflamm. 2008: 875394
- Keskin, D. B., J. N. Stern, M. Fridkis-Hareli, and A. A. Razzaque. 2008. Cytokine profiles in pemphigus vulgaris patients treated with intravenous immunoglobulins as compared with conventional immunosuppressive therapy. Cytokine 41: 315–321
- Javor, J., N. Chmurova, Z. Parnicka, et al. 2010. TNF-alpha and IL-10 gene polymorphisms show a weak association with pemphigus vulgaris in the Slovak population. J. Eur. Acad. Dermatol. Venereol. 24: 65–68
- Shoskes, D. A., Q. Albakri, K. Thomas, and D. Cook. 2002. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response. J. Urol. 168: 331–335
- Westphal, G. A., A. Schnuch, R. Moessner, et al. 2003. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 48: 93–98
- Carrozzo, M., M. Uboldi de Capei, E. Dametto, et al. 2004. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J. Invest. Dermatol. 122: 87–94
- Feliciani, C., P. Toto, P. Amerio, et al. 2000. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J. Invest. Dermatol. 114: 71–77
- D'Auria, L., C. Bonifati, A. Mussi, et al. 1997. Cytokines in the sera of patients with pemphigus vulgaris: interleukin-6 and tumour necrosis factor-alpha levels are significantly increased as compared to healthy subjects and correlate with disease activity. Eur. Cytokine Netw. 8: 383–387
- Elahi, M. M., K. Asotra, B. M. Matata, and S. S. Mastana. 2009. Tumor necrosis factor alpha−308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochem. Biophys. Acta 1792: 163–172
- Lopez-Robles, E., E. Avalos-Díaz, E. Vega-Memije, et al. 2001. TNF alpha and IL-6 are mediators in the blistering process of pemphigus. Int. J. Dermatol. 40: 185–188
- Mosaad, Y. M., H. Fathy, Z. Fawzy, and M. A. El-Saied. 2012. Tumor necrosis factor-alpha−308 G/A and interleukin-6−174 G/C promoter polymorphisms and pemphigus. Hum. Immunol. 73: 560–565
- Eberhard, Y., E. Burgos, J. Gagliardi, et al. 2005. Cytokine polymorphisms in patients with pemphigus. Arch. Dermatol. Res. 296: 309–313
- Torzecka, J. D., J. Narbutt, A. Sysa-Jedrzejowska, et al. 2003. Tumour necrosis factor-alpha polymorphism as one of the complex inherited factors in pemphigus. Mediat. Inflamm. 12: 303–307
- Wu, R., and B. Li. 1999. A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics 55: 355–365
- DerSimonian, R., and N. Laird. 1986. Meta-analysis in clinical trials. Control Clin. Trials 7: 177–188
- Mantel, N., and W. Haenszel. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22: 719–748
- Higgins, J. P., S. G. Thompson, J. J. Deeks, and D. G. Altman. 2003. Measuring inconsistency in meta-analyses. Br. Med. J. 327: 557–560
- Egger, M., G. Davey-Smith, M. Schneider, and C. Minder. 1997. Bias in meta-analysis detected by a simple, graphical test. Br. Med. J. 315: 629–634
- Ben-Ari, Z., E. Mor, O. Papo, et al. 2003. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am. J. Gastroenterol. 98: 144–150
- Feliciani, C., P. Toto, B. Wang, et al. 2003. Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis. Exp. Dermatol. 12: 466–471
- Roxo, V. M., N. F. Pereira, D. P. Pavoni, et al. 2003. Polymorphisms within the tumor necrosis factor and lymphotoxin-alpha genes and endemic pemphigus foliaceus – are there any associations? Tissue Antigens 62: 394–400
- Messer, G., U. Spengler, M. C. Jung, et al. 1991. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J. Exp. Med. 173: 209–219
- Wilson, A. G., J. A. Symons, T. L. McDowell, et al. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94: 3195–3199
- Chen, G., R. Wilson, S. H. Wang, et al. 1996. Tumour necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in pre-eclampsia. Clin. Exp. Immunol. 104: 154–159
- Juszczynski, P., E. Kalinka, J. Bienvenu, et al. 2002. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. Blood 100: 3037–3040
- Brinkman, B. M., D. Zuijdeest, E. L. Kaijzel, et al. 1995. Relevance of the tumor necrosis factor alpha (TNF alpha) −308 promoter polymorphism in TNF alpha gene regulation. J. Inflamm. 46: 32–41
- Pociot, F., A. G. Wilson, J. Nerup, and G. W. Duff. 1993. No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur. J. Immunol. 23: 3050–3053
- Fabris, M., B. Tolusso, E. Di Poi, et al. 2002. Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis. J. Rheumatol. 29: 1847–1850
- Zuniga, J., G. Vargas-Alarcón, G. Hernández-Pacheco, et al. 2001. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun. 2: 363–366
- Castro-Giner, F., M. Kogevinas, M. Machler, et al. 2008. TNFA−308G > A in two international population-based cohorts and risk of asthma. Eur. Respir. J. 32: 350–361
- Raina, P., K. Matharoo, A. Kumar, et al. 2014. Association of tumor necrosis factor-alpha−308 G > A polymorphism with rheumatoid arthritis in two North Indian cohorts. Arch. Rheumatol. 29: 241–249
- Bouillon, R., G. Carmeliet, L. Verlinden, et al. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726–776